ROBERT A BRANCH, M.D.
Osteopathic Medicine in Pittsburgh, PA
License number
Pennsylvania MD043670L
Category
Osteopathic Medicine
Type
Clinical Pharmacology
Address
Address
200 Lothrop St Montefiore 6 NE, Pittsburgh, PA 15213
Phone
(412) 648-6530
(412) 802-8668 (Fax)
(412) 383-7824
(412) 648-1880 (Fax)
(412) 802-8668 (Fax)
(412) 383-7824
(412) 648-1880 (Fax)
Personal information
See more information about ROBERT A BRANCH at radaris.comName
Address
Phone
4814 Welby Dr, Schnecksville, PA 18078
520 Farndale Rd, Pittsburgh, PA 15238
614 Essex Ct, Pittsburgh, PA 15238
4037 Portman St, Pittsburgh, PA 15214
46 Penn Est, East Stroudsburg, PA 18301
Organization information
See more information about ROBERT A BRANCH at bizstanding.comRobert Branch MD
200 Lothrop St, Pittsburgh, PA 15213
Industry:
Genetic Medicine, Pharmacy, Internist
Phone:
(412) 648-6530 (Phone)
Robert Anthony Branch
Robert A Branch MD
100 Technology Dr STE 450, Pittsburgh, PA 15219
Categories:
Physicians & Surgeons
Phone:
(412) 648-1880 (Phone)
Professional information
See more information about ROBERT A BRANCH at trustoria.com
Dr. Robert A Branch, Pittsburgh PA - MD (Doctor of Medicine)
Dr. Robert A Branch, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Clinical Pharmacology, Internal Medicine
Address:
Clinical/Translational Research
200 Lothrop St, Pittsburgh 15213
(412) 648-6530 (Phone)
200 Lothrop St, Pittsburgh 15213
(412) 648-6530 (Phone)
Languages:
English
Hospitals:
Clinical/Translational Research
200 Lothrop St, Pittsburgh 15213
Upmc Presbyterian Shadyside
200 Lothrop St, Pittsburgh 15213
200 Lothrop St, Pittsburgh 15213
Upmc Presbyterian Shadyside
200 Lothrop St, Pittsburgh 15213
Education:
Medical School
University of Bristol / The Medical School
Vanderbilt University Med Center
University of Bristol / The Medical School
Vanderbilt University Med Center
Discovery Of T-Homology In A Set Of Sequences And Production Of Lists Of T-Homologous Sequences With Predefined Properties
Discovery Of T-Homology In A Set Of Sequences And Production Of Lists Of T-Homologous Sequences With Predefined Properties
US Patent:
2011017, Jul 14, 2011
Filed:
Sep 18, 2009
Appl. No.:
13/063832
Inventors:
Petr Pancoska - Pittsburgh PA, US
Robert A. Branch - Pittsburgh PA, US
Patrick M. Dudas - Edinburg PA, US
Robert A. Branch - Pittsburgh PA, US
Patrick M. Dudas - Edinburg PA, US
Assignee:
University of Pittsburgh - Of the Commonwealth System of Higher Education - Pittsburgh PA
International Classification:
G06F 19/00
US Classification:
702 20
Abstract:
System(s) and method(s) for analysis and design of genome sequences are provided. A graph representation of a genome sequence facilitates generation of a thermodynamic based quantity, e.g., an entropy-based and enthalpy-based thermodynamic tolerance [τ], which in turn affords estimation of a gene sequence potential function that depends at least upon structural and functional properties of the gene sequence. The gene sequence potential (Φ) is determined, at least in part, via a generalized Schrödinger equation for the thermodynamic tolerance. Gene sequence potential and thermodynamic tolerance [τ], and derived quantities, like thermodynamic tolerance profile and generalized homology, provide an analytic instrument for characterization of natural and synthetic gene sequences, and in conjunction with graph-based algorithms embodies a tool for design of genome sequences with predetermined properties.
Methods Of Assessment Of Drug Metabolizing Enzymes
Methods Of Assessment Of Drug Metabolizing Enzymes
US Patent:
2004024, Dec 2, 2004
Filed:
Feb 4, 2004
Appl. No.:
10/770538
Inventors:
Robert Branch - Pittsburgh PA, US
Marjorie Romkes - Export PA, US
Marjorie Romkes - Export PA, US
International Classification:
C12Q001/68, G01N033/53, C07H021/04, C12N009/02
US Classification:
435/006000, 435/007100, 435/069100, 435/189000, 435/320100, 435/325000, 536/023200
Abstract:
The invention provides a method for assessing drug metabolizing enzyme expression levels in whole blood. The invention enables prediction of the effectiveness or safety of a drug therapy by providing a measure of the drug metabolizing capability of the patient. The invention provides a method for detecting and quantifying CYP2D6 mRNA in biological samples, a multiplex assay for detecting SNPs of CYP2D6 gene, and a multiplex assay for detecting SNPs of NAT1 and NAT2.